Research Article

Serum Galectin and Renal Dysfunction in ST-Segment Elevation Myocardial Infarction

Table 1

Clinical and demographic characteristics of the patients according to the cystatin C-based estimate of GFR on day 12 after STEMI.

ParametersGFR by cystatin ≥60 mL/min/1.73 m2, GFR by cystatin <60 mL/min/1.73 m2,

Males, (%)32 (72.7)57 (67.9)0.51
Subjects >60 y.o., (%)17 (37.8)39 (46.4)0.34
BMI >25, (%)34 (75.6)66 (81.5)0.43
PICS, (%)5 (11.1)18 (21.4)0.14
Angina pectoris history, (%)20 (44.4)42 (50.0)0.54
Congestive CF history, (%)9 (20.0)13 (15.5)0.51
CVA history, (%)4 (8.9)7 (8.3)0.91
Smoking, (%)21 (46.7)36 (42.9)0.68
DM type 2, (%)16 (33.3)20 (23.8) 0.25
AH history, (%)40 (88.9)71 (84.5)0.49
Kidney disease history, (%)26 (57.8)52 (61.9)0.65
IMC (mm)1.30 (1.20; 1.30)1.20 (1.10; 1.30)0.22
TLT, (%)4 (8.9)9 (10.7)0.74
CAG, (%)45 (100)79 (94.1)0.09
PCI, (%)36 (80.0)63 (75.0)0.52
EF (%)49.00 (46.00; 55.00)48.00 (45.00; 54.00)0.43
EF <40%, (%)4 (8.9)11 (13.1)0.47

Values are (%) or median (25th; 75th percentile). value for differences between groups ().
Note: BMI, body mass index; PICS, postinfarction cardiosclerosis; CHF, congestive heart failure; ACVA, acute cerebrovascular accident; DM, diabetes mellitus; HT, hypertension; IMT, intima/media thickness; TLT, thrombolytic therapy; CAG, coronary angiography; PCI, percutaneous coronary intervention; EF, ejection fraction.